COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
*Mounika Vadiyala | *Mounika Vadiyala | ||
*Sara Haddadi | *Sara Haddadi | ||
'''Dermatologic Disorders of COVID-19 Team Members''' | '''Dermatologic Disorders of COVID-19 Team Members''' | ||
*Nuha Shah | *Nuha Shah | ||
*Hannah Abude | *Hannah Abude | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
* [[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | * [[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | ||
* [[User:Aisha Adigun|Aisha Adigun, M.D.]] | * [[User:Aisha Adigun|Aisha Adigun, M.D.]] | ||
'''Frequently Asked Outpatient Questions Team Members''' | '''Frequently Asked Outpatient Questions Team Members''' | ||
* [[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | * [[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | ||
* [[User:Aisha Adigun|Aisha Adigun, M.D.]] | * [[User:Aisha Adigun|Aisha Adigun, M.D.]] | ||
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]] | *[[User:Bosky Soni|Bosky Soni, M.D., MPH]] | ||
'''Hematologic disorders of COVID-19 Team Members''' | '''Hematologic disorders of COVID-19 Team Members''' | ||
'''Nephrologic Disorders of COVID-19 Team Members''' | '''Nephrologic Disorders of COVID-19 Team Members''' | ||
| Line 40: | Line 44: | ||
*[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | *[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | ||
*Nasrin Nikravan | *Nasrin Nikravan | ||
'''Neurologic Disorders and COVID-19 Team Members''' | '''Neurologic Disorders and COVID-19 Team Members''' | ||
| Line 46: | Line 51: | ||
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | *[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | ||
*[[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | *[[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | ||
'''Ongoing Clinical Trials of COVID-19 Team Members''' | '''Ongoing Clinical Trials of COVID-19 Team Members''' | ||
* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]] | * [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]] | ||
<br /> | * <br /> '''Pulmonary Disorders and COVID-19 Team Members''' | ||
'''Pulmonary Disorders and COVID-19 Team Members''' | |||
*Rana Aljebzi | *Rana Aljebzi | ||
| Line 59: | Line 64: | ||
<br /> | <br /> | ||
'''Other Team Members''' | '''Other Team Members''' | ||
*Oluwabusola Adogba | *Oluwabusola Adogba | ||
*[[User:Rija Gul|Rija Gul, M.D.]] | *[[User:Rija Gul|Rija Gul, M.D.]] | ||
* | |||
*Sara Zand | *Sara Zand | ||
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]] | *[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]] | ||
Revision as of 23:57, 10 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
Cardiovascular Disorders of COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mandana Safakhah
- Mitra Chitsazan
- Mounika Vadiyala
- Sara Haddadi
Dermatologic Disorders of COVID-19 Team Members
- Nuha Shah
- Hannah Abude
Frequently Asked Inpatient Questions Team Members
Frequently Asked Outpatient Questions Team Members
Hematologic disorders of COVID-19 Team Members
Nephrologic Disorders of COVID-19 Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravan
Neurologic Disorders and COVID-19 Team Members
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.B.B.S.
- Harmeet Kharoud, M.D,. MPH
Ongoing Clinical Trials of COVID-19 Team Members
- Huda A. Karman M.D., M.P.H., M.S.
Pulmonary Disorders and COVID-19 Team Members
- Rana Aljebzi
- Ayesha Farheen Javid
Radiologic Manifestations of COVID-19 Team Members
Other Team Members
- Oluwabusola Adogba
- Rija Gul, M.D.
- Sara Zand
- Sogand Goudarzi, M.D.
- Zaida Obeidat
- Vidhi Patel, M.B.B.S.
- Wajeeha Aiman
- Zaida Obeidat